NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $221,000 | +7.3% | 2,341 | -1.3% | 0.01% | 0.0% |
| Q3 2020 | $206,000 | -47.8% | 2,371 | -47.6% | 0.01% | -54.5% |
| Q2 2020 | $395,000 | -4.6% | 4,521 | -10.0% | 0.02% | -18.5% |
| Q1 2020 | $414,000 | -12.3% | 5,021 | +0.7% | 0.03% | +8.0% |
| Q4 2019 | $472,000 | +1.5% | 4,986 | -6.8% | 0.02% | -7.4% |
| Q3 2019 | $465,000 | +17.1% | 5,347 | +23.0% | 0.03% | +17.4% |
| Q2 2019 | $397,000 | -6.6% | 4,347 | -1.7% | 0.02% | -11.5% |
| Q1 2019 | $425,000 | +12.1% | 4,420 | 0.0% | 0.03% | -3.7% |
| Q4 2018 | $379,000 | -0.5% | 4,420 | -0.0% | 0.03% | +17.4% |
| Q3 2018 | $381,000 | -48.1% | 4,422 | -52.8% | 0.02% | -4.2% |
| Q2 2018 | $734,000 | +88.2% | 9,378 | +94.2% | 0.02% | -7.7% |
| Q1 2018 | $390,000 | -7.4% | 4,829 | -3.6% | 0.03% | -10.3% |
| Q4 2017 | $421,000 | +75.4% | 5,010 | +79.2% | 0.03% | +20.8% |
| Q4 2015 | $240,000 | +15.9% | 2,795 | +24.3% | 0.02% | +9.1% |
| Q3 2015 | $207,000 | – | 2,249 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |